New therapeutic approaches for treating CMT and related disorders

Details for Australian Patent Application No. 2008328745 (hide)

Owner Pharnext

Inventors Chumakov, Ilya; Cohen, Daniel; Guerassimenko, Oxana; Nabirochkin, Serguei

Agent Davies Collison Cave

Pub. Number AU-A-2008328745

PCT Pub. Number WO2009/068668

Priority 60/991,800 03.12.07 US; 07301614.9 30.11.07 EP

Filing date 28 November 2008

Wipo publication date 4 June 2009

International Classifications

A61K 31/047 (2006.01)

A61K 31/197 (2006.01)

A61K 31/27 (2006.01)

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4178 (2006.01)

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/068668 Priority application(s): WO2009/068668

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008328754-Novel tissue protective erythropoietin receptor (NEPOR) and methods of use

2008328733-Thuricin CD, an antimicrobial for specifically targeting Clostridium difficile